STOCK TITAN

[Form 4] Crocs, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

John B. Replogle, a director of Crocs, Inc. (CROX), reported purchases of company stock on 08/08/2025. He acquired 336 shares at a weighted-average price of $76.302 and 2,925 shares at a weighted-average price of $76.734, for a total of 3,261 shares added to his holdings. The filings show beneficial ownership of 12,492 shares after the first reported purchase and 15,417 shares following the second reported purchase.

The report discloses that the purchases were executed in multiple transactions with price ranges of $75.550 to $76.426 and $76.595 to $76.750 for the two groups of shares, respectively, and the filer's footnotes offer to provide a breakdown of shares purchased at each price upon request.

John B. Replogle, direttore di Crocs, Inc. (CROX), ha comunicato l'acquisto di azioni della società il 08/08/2025. Ha acquisito 336 azioni a un prezzo medio ponderato di $76.302 e 2,925 azioni a un prezzo medio ponderato di $76.734, per un totale di 3,261 azioni aggiunte alle sue partecipazioni. Le segnalazioni indicano una partecipazione beneficiaria di 12,492 azioni dopo il primo acquisto dichiarato e di 15,417 azioni dopo il secondo acquisto dichiarato.

Il rapporto precisa che gli acquisti sono stati eseguiti in più transazioni con fasce di prezzo rispettivamente di $75.550 a $76.426 e $76.595 a $76.750 per i due blocchi di azioni, e le note del dichiarante offrono, su richiesta, la ripartizione delle azioni acquistate a ciascun prezzo.

John B. Replogle, director de Crocs, Inc. (CROX), informó la compra de acciones de la compañía el 08/08/2025. Adquirió 336 acciones a un precio medio ponderado de $76.302 y 2,925 acciones a un precio medio ponderado de $76.734, sumando en total 3,261 acciones a su posición. Los registros muestran una titularidad beneficiaria de 12,492 acciones tras la primera compra informada y de 15,417 acciones después de la segunda.

El informe indica que las compras se ejecutaron en múltiples operaciones con rangos de precio de $75.550 a $76.426 y de $76.595 a $76.750 para los dos grupos de acciones, respectivamente, y las notas del declarante ofrecen, previa solicitud, el desglose de las acciones compradas a cada precio.

John B. Replogle은 Crocs, Inc. (CROX)의 이사로서 08/08/2025에 회사 주식을 매수했다고 보고했습니다. 그는 가중평균 가격 $76.302에 336주, $76.734에 2,925주를 취득하여 총 3,261주를 보유에 추가했습니다. 신고서에는 첫 매수 후의 수익적 소유권이 12,492주, 두 번째 매수 후에는 15,417주로 기재되어 있습니다.

보고서는 해당 매수들이 여러 건의 거래로 체결되었으며, 두 그룹의 주식에 대한 가격 범위는 각각 $75.550~$76.426 및 $76.595~$76.750였다고 밝히고, 제출인의 각주에는 요청 시 각 가격별로 취득한 주식의 구체 내역을 제공하겠다고 적혀 있습니다.

John B. Replogle, administrateur de Crocs, Inc. (CROX), a déclaré des achats d'actions de la société le 08/08/2025. Il a acquis 336 actions à un prix moyen pondéré de $76.302 et 2,925 actions à un prix moyen pondéré de $76.734, soit au total 3,261 actions ajoutées à ses avoirs. Les dépôts indiquent une détention bénéficiaire de 12,492 actions après le premier achat déclaré et de 15,417 actions après le second.

Le rapport précise que les achats ont été exécutés en plusieurs transactions, avec des fourchettes de prix de $75.550 à $76.426 et de $76.595 à $76.750 pour les deux lots d'actions respectivement, et les notes du déclarant proposent, sur demande, de fournir la ventilation des actions achetées à chaque prix.

John B. Replogle, ein Direktor von Crocs, Inc. (CROX), meldete Aktienkäufe des Unternehmens am 08/08/2025. Er erwarb 336 Aktien zu einem gewichteten Durchschnittspreis von $76.302 und 2,925 Aktien zu einem gewichteten Durchschnittspreis von $76.734, womit insgesamt 3,261 Aktien zu seinem Bestand hinzukamen. Die Meldungen weisen ein wirtschaftliches Eigentum von 12,492 Aktien nach dem ersten gemeldeten Kauf und von 15,417 Aktien nach dem zweiten gemeldeten Kauf aus.

Der Bericht gibt an, dass die Käufe in mehreren Transaktionen ausgeführt wurden, mit Preisbereichen von $75.550 bis $76.426 bzw. $76.595 bis $76.750 für die beiden Aktienblöcke, und die Fußnoten des Meldenden bieten an, auf Anfrage eine Aufschlüsselung der zu jedem Preis gekauften Aktien bereitzustellen.

Positive
  • Director John B. Replogle purchased a total of 3,261 CROX shares, increasing reported beneficial ownership to 15,417 shares.
Negative
  • None.

Insights

Director bought 3,261 CROX shares at ~ $76, modestly increasing direct ownership to 15,417 shares.

The transactions on 08/08/2025 consist of two non-derivative purchases: 336 shares at a weighted-average of $76.302 and 2,925 shares at a weighted-average of $76.734. The filing reports direct beneficial ownership rising from 12,492 to 15,417 shares. The disclosure includes the weighted-average price ranges for the underlying executions, which improves transparency about trade execution. For a public company of Crocs' size these purchases are notable as insider buy activity but are not transformational on their own.

Form 4 properly discloses director purchases and direct beneficial ownership increases with price ranges and weighted averages.

The Form 4 shows the reporting person is a director and that the ownership form is direct (D) for both transactions. Footnotes explicitly state weighted-average prices and the ranges of execution prices, and the filer offers to provide a per-price breakdown if requested, which supports disclosure completeness. The report is routine in form and provides the required specificity for Section 16 reporting.

John B. Replogle, direttore di Crocs, Inc. (CROX), ha comunicato l'acquisto di azioni della società il 08/08/2025. Ha acquisito 336 azioni a un prezzo medio ponderato di $76.302 e 2,925 azioni a un prezzo medio ponderato di $76.734, per un totale di 3,261 azioni aggiunte alle sue partecipazioni. Le segnalazioni indicano una partecipazione beneficiaria di 12,492 azioni dopo il primo acquisto dichiarato e di 15,417 azioni dopo il secondo acquisto dichiarato.

Il rapporto precisa che gli acquisti sono stati eseguiti in più transazioni con fasce di prezzo rispettivamente di $75.550 a $76.426 e $76.595 a $76.750 per i due blocchi di azioni, e le note del dichiarante offrono, su richiesta, la ripartizione delle azioni acquistate a ciascun prezzo.

John B. Replogle, director de Crocs, Inc. (CROX), informó la compra de acciones de la compañía el 08/08/2025. Adquirió 336 acciones a un precio medio ponderado de $76.302 y 2,925 acciones a un precio medio ponderado de $76.734, sumando en total 3,261 acciones a su posición. Los registros muestran una titularidad beneficiaria de 12,492 acciones tras la primera compra informada y de 15,417 acciones después de la segunda.

El informe indica que las compras se ejecutaron en múltiples operaciones con rangos de precio de $75.550 a $76.426 y de $76.595 a $76.750 para los dos grupos de acciones, respectivamente, y las notas del declarante ofrecen, previa solicitud, el desglose de las acciones compradas a cada precio.

John B. Replogle은 Crocs, Inc. (CROX)의 이사로서 08/08/2025에 회사 주식을 매수했다고 보고했습니다. 그는 가중평균 가격 $76.302에 336주, $76.734에 2,925주를 취득하여 총 3,261주를 보유에 추가했습니다. 신고서에는 첫 매수 후의 수익적 소유권이 12,492주, 두 번째 매수 후에는 15,417주로 기재되어 있습니다.

보고서는 해당 매수들이 여러 건의 거래로 체결되었으며, 두 그룹의 주식에 대한 가격 범위는 각각 $75.550~$76.426 및 $76.595~$76.750였다고 밝히고, 제출인의 각주에는 요청 시 각 가격별로 취득한 주식의 구체 내역을 제공하겠다고 적혀 있습니다.

John B. Replogle, administrateur de Crocs, Inc. (CROX), a déclaré des achats d'actions de la société le 08/08/2025. Il a acquis 336 actions à un prix moyen pondéré de $76.302 et 2,925 actions à un prix moyen pondéré de $76.734, soit au total 3,261 actions ajoutées à ses avoirs. Les dépôts indiquent une détention bénéficiaire de 12,492 actions après le premier achat déclaré et de 15,417 actions après le second.

Le rapport précise que les achats ont été exécutés en plusieurs transactions, avec des fourchettes de prix de $75.550 à $76.426 et de $76.595 à $76.750 pour les deux lots d'actions respectivement, et les notes du déclarant proposent, sur demande, de fournir la ventilation des actions achetées à chaque prix.

John B. Replogle, ein Direktor von Crocs, Inc. (CROX), meldete Aktienkäufe des Unternehmens am 08/08/2025. Er erwarb 336 Aktien zu einem gewichteten Durchschnittspreis von $76.302 und 2,925 Aktien zu einem gewichteten Durchschnittspreis von $76.734, womit insgesamt 3,261 Aktien zu seinem Bestand hinzukamen. Die Meldungen weisen ein wirtschaftliches Eigentum von 12,492 Aktien nach dem ersten gemeldeten Kauf und von 15,417 Aktien nach dem zweiten gemeldeten Kauf aus.

Der Bericht gibt an, dass die Käufe in mehreren Transaktionen ausgeführt wurden, mit Preisbereichen von $75.550 bis $76.426 bzw. $76.595 bis $76.750 für die beiden Aktienblöcke, und die Fußnoten des Meldenden bieten an, auf Anfrage eine Aufschlüsselung der zu jedem Preis gekauften Aktien bereitzustellen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
REPLOGLE JOHN B

(Last) (First) (Middle)
C/O CROCS, INC.
500 ELDORADO BLVD #5

(Street)
BROOMFIELD CO 80021

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Crocs, Inc. [ CROX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 P 336 A $76.302(1) 12,492 D
Common Stock 08/08/2025 P 2,925 A $76.734(2) 15,417 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $75.550 to $76.426, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 and 2.
2. The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging $76.595 to $76.750, inclusive.
Remarks:
/s/Sara Hoverstock, Attorney-in-Fact 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did John B. Replogle report on Form 4 for CROX?

The Form 4 reports two non-derivative purchases on 08/08/2025: 336 shares at a weighted-average price of $76.302 and 2,925 shares at a weighted-average price of $76.734.

How many CROX shares does the reporting person beneficially own after these transactions?

The filing shows beneficial ownership of 12,492 shares after the first reported purchase and 15,417 shares after the second reported purchase.

Were the purchases executed at single prices or multiple prices?

The filing states the shares were purchased in multiple transactions. Footnotes give execution price ranges: $75.550 to $76.426 for the first group and $76.595 to $76.750 for the second group, with weighted-average prices reported.

Is the ownership shown as direct or indirect in the Form 4?

The transactions are reported with the ownership form marked as Direct (D) for both purchases.

Does the Form 4 offer additional breakdowns of executed prices?

Yes. Footnotes state the reporting person will provide, upon request, full information regarding the number of shares purchased at each separate price within the disclosed ranges.
Crocs Inc

NASDAQ:CROX

CROX Rankings

CROX Latest News

CROX Latest SEC Filings

CROX Stock Data

4.25B
52.79M
3.18%
101.41%
10.44%
Footwear & Accessories
Rubber & Plastics Footwear
Link
United States
BROOMFIELD